Avicanna Inc (AVCN : TSX)
Common Stock
$0.13
CAD
+0.00 (%)
Last updated: 2026-07-20
AVCN
Avicanna Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+4.17%
1 Month
-3.85%
YTD
-43.18%
Key Statistics
Market Cap
$15.72M
52W High
$0.31
52W Low
$0.10
P/E Ratio
-
50 Day MA
$0.13
200 Day MA
$0.19
Beta
0.33
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/20/2026 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 57,320 |
| 7/17/2026 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 121,192 |
| 7/16/2026 | $0.12 | $0.14 | $0.12 | $0.13 | $0.13 | 84,700 |
| 7/15/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 58,200 |
| 7/14/2026 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 17,000 |
| 7/13/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 4,700 |
| 7/10/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 30,800 |
| 7/9/2026 | $0.13 | $0.13 | $0.12 | $0.13 | $0.13 | 195,576 |
| 7/8/2026 | $0.11 | $0.12 | $0.10 | $0.12 | $0.12 | 997,350 |
| 7/7/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 32,162 |
Analyst Price Targets
Based on analyst covering AVCN
Wall Street analysts forecast AVCN stock price to rise 460.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+460.0% Upside
Current Price
C$0.13
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
78.6%
Annualized
90-Day Vol
66.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.12 | C$0.09 – C$0.15 |
| 60 trading days | C$0.11 | C$0.08 – C$0.16 |
| 90 trading days | C$0.10 | C$0.07 – C$0.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Avicanna Inc
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific cannabinoid-based candidates to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, as well as Trunerox, an indication-specific drug treatment for seizure associated with Lennox-Gastaut Syndrome and Dravet Syndrome. The company also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, it operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, as well as provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens; and collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator's various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $25.83M
- EBITDA
- $-2.64M
- Profit Margin
- -12.09%
- ROE (TTM)
- -26.45%
- EPS (Diluted)
- -0.02
- Book Value
- 0.03
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About AVCN
Articles Featuring AVCN.TO
Latest articles and analysis covering AVCN.TO
Why Avicanna Inc stock is rising today
Avicanna Inc's stock rose by 4.00% in the last trading session, driven by the announcement of its innovative QUIX™ rapid-onset medical cannabis portfolio, which aims to enhance patient access and optimize treatment options.
What's Going On With Avicanna Inc Stock Monday?
Avicanna Inc has introduced the QUIX™ Rapid-Onset Medical Cannabis Portfolio, which may influence its stock performance. The stock closed at C$0.13, down 3.85% today but up 4.17% for the week.
Why Avicanna Inc stock is skyrocketing today
Avicanna Inc (AVCN.TO) has experienced a remarkable 8.33% increase in its stock price, fueled by the announcement of its new QUIX™ rapid-onset medical cannabis portfolio, set to revolutionize patient access in the medical cannabis market.
Why Avicanna Inc stock is skyrocketing today
Avicanna Inc's stock surged by 8.33% following the announcement of its QUIX™ rapid-onset medical cannabis portfolio, indicating strong investor confidence in its innovative approach to cannabinoid delivery.
Why Avicanna Inc stock is rising today
Avicanna Inc's stock rose by 4.17% in the last trading session, closing at CA$0.13, suggesting increased investor confidence amid ongoing developments in the cannabinoid market.
What's Going On With Avicanna Inc Stock Monday?
Avicanna Inc (AVCN.TO) has seen a drop of 4.00% in today's trading, with a notable year-to-date decline of 45.45%. The recent promotion of a new CFO may influence future performance as the company navigates its financial challenges.
Why Avicanna Inc stock is sliding today
Avicanna Inc's stock slid 4.00% in the last trading session, closing at CA$0.12. The decline raises concerns about the company's performance amid a lack of recent positive news.
Why Avicanna Inc stock is rising today
Avicanna Inc's stock rose by 4.17% in the last session, closing at CA$0.13. This increase may indicate a positive shift in investor sentiment, driven by the company's strategic initiatives in the cannabinoid sector.
Why Avicanna Inc stock is rising today
Avicanna Inc's stock has risen by 4.17% today, closing at CA$0.13. This increase reflects investor optimism about the company's strategic initiatives and market expansion efforts.
Why Avicanna Inc stock is plummeting today
Avicanna Inc's stock has dropped sharply, closing at CA$0.10 after a 13.04% decline. This downturn raises questions about the company's stability and future prospects in a competitive market.
Why Avicanna Inc stock is sliding today
Avicanna Inc's stock price fell 4.17% in the last session, raising questions about the company's future amidst a competitive and volatile cannabis market.
Why Avicanna Inc stock is plummeting today
Avicanna Inc's stock has fallen sharply, closing down 7.69% in the last trading session, raising questions about the company's future amidst leadership changes and market volatility.
Why Avicanna Inc stock is rising today
Avicanna Inc's stock rose by 4.17% in the last trading session, driven by strategic investments and positive market sentiment in the cannabinoid healthcare sector.
Why Avicanna Inc stock is sliding today
Avicanna Inc's stock fell by 4% in the last trading session, closing at CA$0.12. Despite some strategic investments, the market's reaction highlights ongoing concerns about the company's growth trajectory.
Why Avicanna Inc stock is sliding today
Avicanna Inc's stock slid 4% in the last trading session, closing at CA$0.12. This decline raises concerns about the company's financial stability and market position in the competitive cannabis sector.
Why Avicanna Inc stock is sliding today
Avicanna Inc's stock slid 4% today, closing at CA$0.12, raising questions about its future performance amidst competitive pressures in the cannabis industry.
Why Avicanna Inc stock is skyrocketing today
Avicanna Inc's stock surged by 6.12% in the last trading session, closing at CA$0.13. This increase highlights investor optimism surrounding the company's strategic initiatives and market positioning.
Why Avicanna Inc stock is rising today
Avicanna Inc (AVCN.TO) has seen a 2.04% increase in stock price, driven by strategic investments and positive financial results, suggesting potential growth in the cannabinoid healthcare sector.
Why Avicanna Inc stock is rising today
Avicanna Inc's stock has risen by 3.85% in a single trading day, driven by strategic investments and a strong market position in the cannabinoid biopharmaceutical sector. As the company continues to expand its capabilities, investors are taking notice of its potential for future growth.
Why Avicanna Inc stock is tanking today
Avicanna Inc. sees its stock price drop by 1.89% as investor confidence wanes amidst recent developments and ongoing challenges in the cannabinoid sector.
Showing latest 20 articles